C.D.C. Panel Will Discuss Blood Clot Risk Linked to J.&J.'s Vaccine

On Thursday, agency advisers will review updated figures showing roughly nine deaths from the rare disorder, according to a federal official.

Related Keywords

Washington ,District Of Columbia ,United States ,Jake Sargent ,Centers For Disease ,Drug Administration ,Advisory Committee On Immunization Practices ,Pfizer ,Astrazeneca ,Washington Post ,Johnson ,Disease Control ,Advisory Committee ,Immunization Practices ,Blood Clot ,Vaccines Immunization ,Coronavirus Covid 19 Pandemic ,Cdc ,Johnson Amp ,